These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12910967)

  • 1. [Pharmacokinetics of salazosulfapyridine in a hemodialysis patient].
    Akiyama Y; Fujimaki T; Sakurai Y
    Ryumachi; 2003 Jun; 43(3):569-76. PubMed ID: 12910967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective study of salazosulfapyridine in eight patients with rheumatoid arthritis on hemodialysis.
    Akiyama Y; Sakurai Y; Kato Y; Furuta E; Mimura T
    Mod Rheumatol; 2014 Mar; 24(2):285-90. PubMed ID: 24252022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dialysis on the pharmacokinetics of salazosulfapyridine.
    Inami Y; Yamaji K; Sato M; Gohda T; Io H; Nawata M; Hamada C; Takasaki Y; Tomino Y
    Rheumatol Int; 2013 Feb; 33(2):535-9. PubMed ID: 22080212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Megaloblastic anemia associated with salazosulfapyridine treatment for rheumatoid arthritis].
    Nakayama S; Yokote T; Kobayashi K; Hirata Y; Hara S; Akioka T; Miyoshi T; Tsuji M; Takubo T; Hanafusa T
    Rinsho Ketsueki; 2008 Dec; 49(12):1609-13. PubMed ID: 19110522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
    Zheng W; Winter SM; Mayersohn M; Bishop JB; Sipes IG
    Drug Metab Dispos; 1993; 21(6):1091-7. PubMed ID: 7905389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beneficial effect of salazosulfapyridine (SASP) in a patient with secondary renal amyloidosis].
    Hidaka M; Ohsawa I; Endo M; Fujita T; Ohi H; Kanmatsuse K; Kusumi Y; Yamaguchi Y
    Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):555-9. PubMed ID: 9805922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyltransferase 2 genotype-related efficacy of sulfasalazine in patients with rheumatoid arthritis.
    Kumagai S; Komada F; Kita T; Morinobu A; Ozaki S; Ishida H; Sano H; Matsubara T; Okumura K
    Pharm Res; 2004 Feb; 21(2):324-9. PubMed ID: 15032315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The indications for the use of salazosulfapyridine in rheumatoid arthritis patients].
    Taneichi K; Baba Y; Sakai I; Shibaki H
    Ryumachi; 1994 Aug; 34(4):744-51. PubMed ID: 7974025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of salazosulfapyridine and its metabolites on immunocompetent cells].
    Ishibashi T; Hara A; Tsuboi I; Muraoka T; Shibata H; Tsunosue R; Shichijo S; Yokoyama M
    Ryumachi; 1989 Jun; 29(3):178-84. PubMed ID: 2573159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis.
    Don BR; Spin G; Nestorov I; Hutmacher M; Rose A; Kaysen GA
    J Pharm Pharmacol; 2005 Nov; 57(11):1407-13. PubMed ID: 16259772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment].
    Guastavino E; Litwin NH; Heffes Nahmod L; Licastro R
    Acta Gastroenterol Latinoam; 1988; 18(2):107-13. PubMed ID: 2908013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individualized sulfasalazine treatment of ulcerative colitis and monitoring of patient compliance by determining sulfapyridine serum concentration].
    Klugmann HJ; Giehler B; Lohmann D; Schiedewitz W
    Gastroenterol J; 1990; 49(4):160-4. PubMed ID: 1970478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of rheumatoid spondylarthritis with salazosulfapyridine].
    Hilliquin P; Munoz A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1991; 58(7):535-41. PubMed ID: 1681585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetyltransferase 2 genotype correlates with sulfasalazine pharmacokinetics after multiple dosing in healthy Japanese subjects.
    Kita T; Sakaeda T; Adachi S; Sakai T; Aoyama N; Hatanaka H; Kasuga M; Okumura K
    Biol Pharm Bull; 2001 Oct; 24(10):1176-80. PubMed ID: 11642327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age.
    Clarke DF; George D; Milsap RL; Pogonowska-Wala E; Owerbach J; Lebenthal E; Jusko WJ
    Pediatr Pharmacol (New York); 1982; 2(4):323-33. PubMed ID: 6152489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients.
    Perry SL; O'Shea SI; Byrne S; Szczech LA; Ortel TL
    Thromb Haemost; 2006 Dec; 96(6):750-5. PubMed ID: 17139369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.